Wouter Plattel
Overview
Explore the profile of Wouter Plattel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Federico M, Plattel W, Hutchings M, Stepanishyna Y, Fortpied C, Andre M
J Clin Oncol
. 2024 Apr;
42(18):2237-2238.
PMID: 38593392
No abstract available.
2.
Zhong Y, Tan G, Bult J, Veltmaat N, Plattel W, Kluiver J, et al.
BMC Cancer
. 2024 Apr;
24(1):407.
PMID: 38566053
Background: Primary central nervous system lymphoma (PCNSL) are rare mature B-cell lymphoproliferative diseases characterized by a high incidence of MYD88 L265P and CD79B Y196 hotspot mutations. Diagnosis of PCNSL can...
3.
Federico M, Fortpied C, Stepanishyna Y, Gotti M, van der Maazen R, Cristinelli C, et al.
J Clin Oncol
. 2023 Nov;
42(1):19-25.
PMID: 37967311
JCO The primary analysis of the Early positron emission tomography (ePET) Response-Adapted Treatment in localized Hodgkin Lymphoma H10 Trial demonstrated that in ePET-negative patients, the risk of relapse increased when...
4.
Meeuwes F, Brink M, Plattel W, van der Poel M, Kersten M, Wondergem M, et al.
Haematologica
. 2023 Oct;
109(4):1163-1170.
PMID: 37794805
Peripheral T-cell lymphomas (PTCL) comprise a heterogeneous group of mature T-cell neoplasms with an unfavorable prognosis; presentation with stage I(E) disease is uncommon. In clinical practice, an abbreviated chemotherapy treatment...
5.
Langendonk M, Smit N, Plattel W, Diepstra A, van Meerten T, Visser L
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430230
The treatment of young patients with Hodgkin lymphoma (HL) is often successful but a significant proportion of patients suffers from late toxicity. In the current era there are new opportunities...
6.
Kilsdonk M, Veldman C, Rosati S, Plattel W, Diepstra A
Histopathology
. 2022 Nov;
82(3):495-503.
PMID: 36345263
Aims: Classic Hodgkin lymphoma (cHL) should be distinguished from its wide variety of histological mimics, including reactive conditions and mature B and T cell neoplasms. Thymus and activation-related chemokine (TARC)...
7.
Brink M, Meeuwes F, van der Poel M, Kersten M, Wondergem M, Mutsaers P, et al.
Blood
. 2022 May;
140(9):1009-1019.
PMID: 35544601
Patients aged <65 years with peripheral T-cell lymphoma (PTCL) are treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Although the addition of etoposide (CHOEP) and consolidation with autologous stem cell...
8.
Al-Sarayfi D, Meeuwes F, Munnink T, Plattel W, Rosati S, Matutes E, et al.
Ann Hematol
. 2021 Jun;
101(3):703-704.
PMID: 34086065
No abstract available.
9.
Nijland M, Bakker M, Meijer K, Plattel W
Ann Hematol
. 2020 Apr;
99(12):2947-2948.
PMID: 32296911
No abstract available.
10.
Klaassen S, Lemmink H, Bijzet J, Glaudemans A, Bos R, Plattel W, et al.
Cardiovasc Pathol
. 2017 May;
29:19-22.
PMID: 28460244
Objective: The clinical description of a novel TTR gene mutation characterized by a late onset amyloid cardiomyopathy. Methods And Results: A 78-year-old man of Dutch origin with recent surgery for...